# Prevalence, etiology, and consequences of anemia and clinical and economic benefits of anemia correction in patients with chronic kidney disease: An overview

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/prevalence-etiology-and-consequences-of-anemia-and-clinical-and-economic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Thomas C. Dowling |
| Citations | 75 |
| DOI | 10.2146/ajhp070181 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2153503887 |
| PMID | 17591994 |
| Type | article |
| Year | 2007 |

## Paper authors

- [Thomas C. Dowling](https://scholariq.org/researchers/thomas-c-dowling/)

## Paper journal

- [American Journal of Health-System Pharmacy](https://scholariq.org/journals/american-journal-of-health-system-pharmacy/)

## Paper primary topic

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)

## Paper topics

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.